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IMPROVING SEMEN IDENTIFICATION AND QUANTITATION USING 
PROTEIN MASS SPECTROMETRY 
 
 
SYDNEY L. NILES 
 
ABSTRACT 
Studies have highlighted a growing national problem regarding the number of 
untested Sexual Assault Kits (SAKs). A 2011 National Institute of Justice report revealed 
Los Angeles alone had 10,000 untested SAKs. This backlog has fueled the need for specific 
and efficient testing of SAK evidence.  In traditional workflows, serology tests are used to 
indicate the presence of a targeted bodily fluid and prioritize samples for genetic analysis.  
However, given the lack of sensitivity and specificity of modern serological assays, current 
SAK workflows often skip serological identification altogether for a “direct to DNA” 
approach. While these Y-Screen workflows achieve rapid screening of samples for the 
presence of a detectible male contributor, they do not provide any serological information. 
As a result, samples lack what can be critical investigative context. Improved serological 
capabilities with enhanced sensitivity and specificity would provide greater confidence in 
results for the confirmatory identification of seminal fluid. At a minimum, forensic 
biologists should understand the limitations associated with traditional serological 
approaches to seminal fluid identification when processing SAK samples.   
Current serological techniques based on antigen-antibody binding have exhibited 
both sensitivity and specificity limitations. False positive results for semen can be obtained 
by non-target biological fluids such as breast milk, urine, and vaginal fluid, or by non-
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specific binding events. This study evaluates a promising emerging technique that 
combines high specificity protein biomarker detection with targeted mass spectrometry. 
This research targeted human-specific peptide markers for seminal fluid proteins and 
peptide standards to perform quantification of seminal fluid peptide targets using an 
Agilent 6495 mass spectrometer coupled to a 1290 series liquid chromatograph. This 
approach has shown to be both more specific and sensitive in identifying a bodily fluid 
compared to current immunological based approaches. Thus, this proteomic workflow was 
used to evaluate authentic false positive rates of current immunochromatographic 
techniques for seminal fluid identification. 
Self-collected vaginal swabs collected from participants not engaging in barrier-
free vaginal intercourse with male partners were tested using various 
immunochromatographic assays designed to detect both semenogelin (Sg) (RSID™-
Semen) and prostate specific antigen (PSA) (ABAcard® p30 Test and SERATEC PSA 
Semiquant). Similarly, three seminal fluid biomarkers (semenogelin 1, semenogelin 2, and 
prostate specific antigen) were used for seminal fluid identification via mass spectrometry.  
Any samples producing positive results on any immunochromatographic assay were 
evaluated to determine whether the target protein was actually present at levels above the 
reported sensitivity limits of the lateral flow tests. Additionally, Sperm HY-LITER™ 
Express was used to microscopically confirm the absence of spermatozoa in all samples 
producing positive immunochromatographic results.  
In addition to using the quantitative proteomic assay to estimate the rate of authentic 
false positive results associated with lateral flow assays, this research sought to establish 
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the correlation (or lack thereof) between absolute quantitation of seminal fluid markers and 
the ability to successfully generate DNA profiles.  Self-collected post-coital swabs from 
donors engaging in barrier free vaginal intercourse with male partners over varied periods 
of time between 1-8 days after intercourse were collected.  All samples were analyzed 
using the quantitative seminal fluid protein mass spectrometry assay, once again targeting 
SgI, SgII, and PSA. Both autosomal STR profiles (GlobalFiler™) and Y-STR profiles 
(Yfiler™ Plus) were subsequently generated. 
With regard to immunochromatographic assay false positive rates, a total of 17 false 
positives for semen were observed (n=150), 14 of which were consistent with PSA and 3 
with Sg, for a corresponding total false positive rate of 9.3% and 2%, respectively (11.3% 
overall).  These samples were all confirmed to be sperm negative with mass spectrometry 
and microscopic analysis. This data supports the use of current immunochromatographic 
assays for the presumptive detection of seminal fluid while also providing further support 
for the improved specificity of alternative serological approaches using mass spectrometry 
identification of biological targets.   
With regard to the relationship between quantitative levels of target seminal fluid 
peptides and the ability to generate STR profiles from vaginal swabs collected at various 
post coital intervals, a total of 61 post-coital samples were tested.  Of these, 48 samples 
had a seminal fluid target greater than the limit of quantitation for the mass spectrometry 
assay and 26 produced an STR (n=9) and/or Y-STR (n=10) profile. A correlation between 
peptide quantitation and ability to generate a genetic profile was unable to be determined 
from this initial sample set.  Overall, however, it has been demonstrated that the use of 
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proteomic mass spectrometry for the identification of seminal fluid targets (with its 
enhanced sensitivity and specificity) would enable forensic practitioners to make better use 
of serological information during the analysis of challenging sexual assault samples.   
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1. INTRODUCTION 
1.1 Sexual Assault  
Sexual assault is currently a prominent issue in the United States, with a 2017 
Uniform Crime Report estimating a total of 135,755 rapes reported to law enforcement 
agencies.1  Given the prevalence of sexual assault in society, the proper collection of sexual 
assault evidence is extremely important. A sexual assault kit (SAK) is used to document 
details of the assault as well as collect any biological evidence from the victim. Physical 
evidence collected includes, but is not limited to, oral, rectal, and vaginal swabs from the 
victim.2 However, research has shown that there is a backlog of SAKs in crime labs and 
law enforcement agencies across the country. In particular, a 2011 National Institute of 
Justice report revealed Los Angeles alone had 10,000 untested SAKs.3  These backlogs 
have become a problem for forensic laboratories and law enforcement agencies as many 
do not have the proper resources or procedures in place to keep up with the growing number 
of SAKs.4 
Detecting the presence of semen is an important aspect of a sexual assault 
investigation, given it provides evidence that sexual contact occurred as well as provides 
potential genetic information of the perpetrator of the crime. In a traditional sexual assault 
kit workflow, serological testing is performed first in order to determine whether seminal 
fluid is present. If a positive result is observed, deoxyribonucleic acid (DNA) analysis 
would be subsequently performed. However, this workflow is not completely efficient and 
can be laborious.  In regards to serological testing, often a series of tests are needed in 
sequence, as appropriate; typically this involves presumptive tests followed by 
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confirmatory assays. These tests can be destructive and time consuming in nature.  Further, 
serological testing methodologies suffer from both sensitivity and specificity limitations.  
Presumptive tests have exhibited cross-reactivity with other non-target body fluids and 
organic acids.  As they typically require enzymatic activity and/or structural integrity of 
targets, their ability to detect seminal fluid targets several days into the post-coital window 
is limited due to the breakdown of proteins. Lastly, in autosomal STR analysis, it can be 
difficult to detect a male profile when there is a limited amount of semen in an 
overabundance of female epithelial cells.  
 Another workflow carried out in SAK testing includes Y-screening methods. In 
these approaches, a sexual assault kit sample would forego serological screening and 
instead be submitted directly for DNA analysis. In particular, quantitative detection of male 
DNA by Y-chromosome targeting is employed.  While efficient at screening for the 
presence of a male contributor, this workflow fails to provide any contextual information 
regarding the biological source of DNA. With more sensitive DNA chemistries, this 
approach fails to identify whether a DNA profile originated from a body fluid or “touch 
DNA” that could have been deposited through primary, secondary or indirect transfer of 
epithelial cells.  
These limitations highlight the need for a more efficient workflow for the 
confirmatory identification of semen.  A novel technique, protein mass spectrometry, has 
shown the ability to identify body fluids such as blood, saliva, semen, and vaginal fluid, 
based on protein biomarkers.5 It offers improved sensitivity and specificity to currently 
employed serological techniques, with no evidence of cross-reactivity with non-target 
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substances.6  Further, it does not consume any evidence required for DNA analysis and is 
compatible with genetic workflows. This technique, therefore, offers promise as a 
confirmatory technique that could help improve the SAK backlog and workflow. 
 
1.2 Semen Identification 
Semen is a commonly encountered body fluid that must often be identified during 
the processing of sexual assault kit evidence.  It is constituted of a mixture of components 
originating from the testes, seminal vesicles, prostate, and bulbourethral glands.   Seminal 
plasma is the non-cellular, or fluid component of semen, while seminal fluid is the 
combination of seminal plasma and cells.  Three seminal fluid proteins, acid phosphatase 
(AP), prostate specific antigen (PSA) or protein p-30 (p30), and semenogelin (Sg) are 
commonly used in forensic testing to presumptively indicate the presence of semen6.  
Acid phosphatase is an enzyme that cleaves phosphate groups from substrates while 
the PSA glycoprotein is a serine protease responsible for the cleavage of Sg; both originate 
from the prostate gland.  The Sg isoforms (Sg I and Sg II) are seminal vesicle proteins 
produced in the seminal vesicle that make up the main component of semen coagulum7, 8.  
The presence of these proteins can be used as a presumptive indication for seminal fluid 
because they are present in other body fluids/tissues, though at lower concentrations. PSA 
can also be found in urine, fecal matter, sweat, and milk, while Sg has been found in other 
body tissues such as the skeletal muscle, kidney, colon, and trachea.7 
One of the main cellular components of semen is spermatozoa, which is produced 
in the testes and stored in the epididymis until ejaculation. Each spermatozoon consists of 
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a head (which contains the acrosome), a mid-piece section, and a tail.  The head contains 
the nucleus and the mid-piece contains the mitochondria.7  The tails of sperm are very 
fragile, and therefore the mid-piece and tail may easily disassociate from the head. 
Currently, the only way to confirm the presence of semen during forensic testing is the 
microscopic visualization of spermatozoa.  
 
1.2.1 Immunochromatographic Assays 
 Lateral flow immunochromatographic assays are tests used to identify a target 
analyte in a liquid matrix. These tests consist of a cartridge with a cellulose membrane that 
allows sample extract to flow across the cartridge. In forensic testing, these immunoassays 
can be used to detect the presence of blood, semen, and saliva.9  In regards to semen 
identification, immunochromatographic tests are used to indicate the presence of either 
PSA/p30 or Sg.  Despite evidence that immunochromatographic assays will cross-react 
with other bodily fluids or undergo non-specific binding events, they are still considered 
by some to be a confirmatory technique for seminal fluid identification7. 
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1.2.2 ABAcard® p30 Immunochromatographic Assay 
  The ABAcard® p30 test (Abacus Diagnostics, West Hills CA) is a qualitative test 
used to detect Protein-p30.  The cartridge membrane contains a sample, test, and control 
region. The sample region contains mobile, dye labeled monoclonal antihuman p30 
antibodies.10 The test region contains immobile monoclonal antihuman p30 antibodies and 
the control region contains immobile anti-immunoglobulin antibodies. If p30 antigen is 
present in a sample, it will bind to the antibody present in the sample area forming an 
antibody-antigen complex. Due to capillary effects in the membrane, the complex is able 
to migrate to the test zone where it is captured by the immobilized antibody, forming an 
antibody-antigen-antibody sandwich. The conjugate pink dye particles bound to the sample 
well antibodies will accumulate at the test zone, forming a pink line if the p30 concentration 
in the sample is greater than 4 ng/mL. Further, p30 antibody-dye conjugates will form a 
complex with immobilized antibody located in the control region in the presence and 
absence of target antigen, forming a visible line in the control region ensuring the test is 
working properly. In the absence of target p30 antigen, a band should only form in the 
control area and not the test zone.  
Validation studies have shown the ABAcard® p30 test to be able to detect semen 
up to dilutions of 1/1,000,000 and to be primate and human specific.11-13  However, the 
ABAcard® p30 test is susceptible to false negative results due to the high dose hook 
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effect10.  Further, it has been reported to yield false positive results from male urine samples 
and other non-target fluids.6, 12-14   
 
1.2.3 Seratec® PSA Semiquant Immunochromatographic Assay 
 The Seratec® PSA Semiquant test (Seratec®, Goettingen, Germany) is used to 
detect the presence of prostate specific antigen.  This test is semi-quantitative so in addition 
to the sample, test, and control regions, it contains an internal standard region. A mobile 
gold-labeled anti-PSA-antibody is present in the sample region of the 
immunochromatographic assay.15   Both the control region and the internal standard region 
contain immobilized polyclonal goat anti-mouse antibodies that are specific to the sample 
well antibody. The test region contains immobilized monoclonal anti-PSA antibody. If 
PSA is present in a sample, it will bind with the antibody present in the sample region and 
form a PSA-gold-labeled anti-PSA antibody complex. This complex will migrate to the 
test zone and form an antibody-antigen-antibody sandwich, producing a pink line if the 
concentration of PSA is at least 4 ng/mL.  Further, to indicate that the test is working 
properly, the gold-labeled anti-PSA antibody located in the sample region will bind with 
the anti-mouse-antibody present in both the control and internal standard region, producing 
two more pink lines independent of the presence of PSA.  The intensity of the internal 
standard line correlates with an amount of 4 ng/mL of PSA present in the sample.  If no 
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PSA is present in the sample, then lines will form at only the control and internal standard 
region.  
 Manufacturer studies show that the PSA Semiquant test is primate and human 
specific and is capable of detecting semen at a dilution of 1/1,000,000.15, 16 However, this 
test is susceptible to the high dose hook effect.15 Further, studies have shown false positive 
results have occurred in female and male urine, breast milk, semen-free vaginal samples, 
and non-biological samples containing an organic acid with a pH below 4.017-20. 
 
1.2.4 RSID™-Semen Immunochromatographic Assays 
 The RSID™-Semen (Independent Forensics, Lombard IL) assay is a qualitative test 
used to detect the presence of semenogelin.  The sample well contains mobile, dye-labeled 
monoclonal mouse anti-human semenogelin antibodies that are conjugated to colloidal 
gold.21 Immobile mouse anti-human semenogelin antibodies are present on the test strip 
and immobilized anti-mouse IGg antibodies are present on the control strip. If semenogelin 
is present in the sample, it will bind with the antibody conjugated to colloidal gold in the 
sample area and form a semenogelin-antibody-gold complex. This complex will migrate 
to the test line where it is captured by the antibodies present on the test strip, forming a 
pink line.  The immobilized anti-mouse IGg at the control line will capture the mouse 
antibodies released from the sample area, producing a pink line. If no semenogelin is 
present in the sample, a band will only be present in the control area and not the test zone. 
The manufacturer reports that the RSID™-Semen test is human specific and is sensitive 
enough to detect 1 nL (nanoliter) of semen.21  However, this test is susceptible to the high 
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dose hook effect when large amounts of human semen are analyzed. Further, semenogelin 
can be found in other body tissues such as the colon, kidney, and skeletal muscle and given 
its reliance on antibody-antigen interactions is susceptible to non-specific binding 
events.6,22 
 
1.3 Microscopic Analysis 
 Microscopic visualization of spermatozoa is the most widely accepted confirmatory 
technique for the identification of semen.9  Commonly used staining techniques include 
Kernechtrot-Picroindigocarmine (Christmas Tree Stain) and Hematoxylin-Eosin.  These 
methods rely on the differential staining patterns of sperm cells compared to other cells, as 
well as the unique morphological features of spermatozoa.  Even though these methods are 
confirmatory, they still possess some limitations.   Visualizing a sperm cell under a 
microscope can be an extremely difficult process, especially when a small amount of 
spermatozoa are present in an abundance of epithelial cells that can mask the spermatozoa.  
Degradation and drainage from the vaginal vault can further make identification difficult, 
and the technique is not applicable in cases of vasectomy and azoospermia.  
Another staining technique used for microscopic identification of sperm is Sperm 
Hy-Liter™ Express (Independent Forensics, Lombard IL).  This method stains sperm 
heads with a fluorescent dye so they can be easily identified under a fluorescent 
microscope. Specifically, the sperm head is fluorescently tagged using a CF™488A 
derivatized mouse monoclonal antibody that targets an antigen specific to the nuclear 
membrane in the sperm head. Further, a second fluorescent dye, DAPI, is used to 
9 
fluorescently tag all nuclei in the sample. 23, 24  After completing the staining procedure, 
samples are viewed under a fluorescent microscope with compatible filters. Any sperm 
heads present will appear fluorescent green and any other nuclear material will appear 
fluorescent blue. The Sperm Hy-Liter™ Express technique is considered confirmatory 
because the CF™488A is specific for human sperm heads. Sperm Hy-Liter™ is able to 
overcome the some of the limitations associated with traditional staining techniques as its 
fluorescent properties facilitate and reduce the search time needed for microscopic 
visualization. The fluorescent appearance of the sperm heads allows for easy recognition 
of sperm cells and prevents masking by epithelial cells.23  This technique, however, may 
produce poor spermatozoa morphology with degraded samples and once again is not 
applicable in cases involving males who are vasectomized or suffer from azoospermia.    
 
1.4 DNA Analysis of Sexual Assault Samples 
 Another important component of processing sexual assault evidence is determining 
the DNA profile of the assailant.  During a physical examination following a sexual assault, 
any areas in which the victim indicated that sexual contact or ejaculation occurred are 
swabbed for forensic analysis. Seminal fluid is able to provide both an autosomal short 
tandem repeat (STR) profile as well as a Y-STR haplotype.  During traditional DNA 
analysis, STR sequences found on autosomal chromosomes are targeted for analysis and 
comparison. While autosomal STR profiling is able to individualize a sample and establish 
the identity of a male contributor, sexual assault samples can contain an excess of victim 
epithelial cells, hindering or precluding the detection of the male contributor.  In such cases, 
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especially those in which spermatozoa are not detected, amplification of male specific Y-
STRs is used.  During Y-STR analysis, STR sequences located on the Y-chromosome are 
targeted.  
 After a sexual assault, a victim may not report the incident and submit for a physical 
examination for days after it occurred.  As the post-coital interval is extended, it becomes 
more difficult to obtain a male DNA profile.  Literature has shown that it can be difficult 
to obtain an autosomal STR profile when swabs are collected more that 48 hours after 
intercourse.25, 26 Loss of sperm after intercourse can be attributed to vaginal drainage or the 
natural degradation of semen in the vaginal cavity. 
 As mentioned above, Y-STR analysis may overcome sensitivity issues, especially 
in cases involving large amounts of female DNA masking the lower amounts of male 
DNA.27 Specifically, literature shows that a full Y-STR profile can be obtained 3-4 days 
after the incident, while at 5-6 days post-coitus, it was more common to observe a partial 
profile.28 However, novel Y-STR techniques have helped obtain Y-STR profiles up to 9 
days after intercourse.29 Therefore, Y-STR profiling can help extend the post-coital interval 
in identifying a male genetic profile.  The adoption of serological methodologies that could 
match the sensitivity level of genetic analysis would prove beneficial in the analysis of 
sexual assault kit samples.  
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1.5 Proteomics 
 Several emerging techniques are being studied in the field of forensics in order to 
overcome the current limitations associated with serological testing. One technique, 
proteomics, or the systematic analysis of all proteins in a tissue or cell, has become an area 
of great interest.30  Proteins are biomolecules that consist of one or more polypeptides, a 
linear chain of amino acids. The sequence of amino acids, as determined by the sequence 
of nucleotides in a gene, differentiates proteins. When coupled with high-specificity 
peptide biomarkers, separation techniques such as targeted mass spectrometry can use mass 
and charge state to identify peptides of interest for the confirmation of biological fluids7.  
The development of two ionization techniques, Electrospray Ionization (ESI) and 
Matrix Assisted Laser Desorption/Ionization (MALDI), have made mass spectrometry 
accessible to analyzing biomolecules because of their ability to accurately determine the 
molecular mass of proteins.30  Mass spectrometry has since become a central technique 
used to analyze these protein biomarkers. For forensic applications, mass spectrometry has 
been used to identify fluid specific peptides in order to differentiate body fluids as well as 
quantify the amount of peptide present.31, 32 Further, it has been used to identify over 100 
seminal fluid proteins and peptides.33 Therefore, the detection of seminal fluid specific 
peptides could be used as a viable confirmatory technique for the forensic identification of 
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semen. Protein mass spectrometry has advantages in that it is highly sensitive and specific, 
can be multiplexed, and consumes only a small amount of evidence.  
   
1.5.1 Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) 
 Liquid Chromatography (LC) is a technique used to separate components of a 
mixture based on their affinity for a mobile phase or stationary phase. In LC, the stationary 
phase is the LC column, and the mobile phase is a solvent used to move the sample into 
the mass spectrometer following elution from the LC column. When a sample is introduced 
to the LC, it’s components will separate based on their intermolecular interactions with 
either the stationary or mobile phase. An analyte with a higher affinity for the mobile phase 
will travel through the column at a faster rate, while an analyte with a higher affinity for 
the stationary phase will travel through the column at a slower rate.  The specific amount 
of time it takes for an analyte to elute off of the column is known as the retention time.  
 A tandem mass spectrometer (MS/MS) is an analytical instrument used to ionize 
compounds and detect them based on their mass to charge (m/z) ratio. A mass spectrometer 
consists of an ionization chamber, a mass-analyzer, and a detector. Electrospray Ionization 
(ESI) is a soft ionization technique used to ionize the analytes introduced into the mass 
spectrometer. During ESI, the liquid solution resulting from the LC is converted to a 
gaseous phase. The sample enters the ionization chamber in a needle and a high voltage is 
applied, dispersing the liquid into a fine spray of charged droplets.34  The positively 
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charged droplets then enter a high temperature vacuum in which they are converted to the 
gas-phase ions before entering the mass analyzer. 
 In a tandem mass spectrometer, the mass analyzer consists of 4 parallel metal rods 
and is set up as 3 quadrupoles. In the first quadrupole, a specific m/z ratio precursor/parent 
ion is targeted to pass through, and excludes all other m/z ratio ions. The second quadrupole 
acts as a collision cell, where the selected m/z ratio charge ions are fragmented into 
product/daughter ions by collision with an inert gas. The third quadrupole serves as a filter 
for the product ions produced, allowing them to pass to the detector.  Resulting data is 
reported in the form of a mass spectrum.35 
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2. MATERIALS AND METHODS 
2.1 Sample Collection and Solubilization of Semen-free Samples 
 Vaginal swab samples were self-collected from 14 anonymous donors abstaining 
from barrierless sexual intercourse using a sterile cotton swab (i.e., clean vaginal swabs). 
Samples were collected in duplicate for a total of 50 swabs and transported to the laboratory 
in coin envelopes. All samples were stored at -80°C until use.  For solubilization of the 
swabs, the cotton tip was removed with a sterile scalpel and placed in a 1.5 mL tube.  Each 
swab was solubilized in 1 mL of RSID™ Universal Buffer (Independent Forensics, 
Lombard IL) for 30 minutes with periodic vortexing every five minutes. Each swab cutting 
was then placed in a spin basket and centrifuged for ten minutes at 10,000 revolutions per 
minute (rpm).  The swabs were discarded and 950 µL of supernatant from each sample was 
transferred to a new 1.5 mL tube, with the pellet remaining in the original tube. The pellet 
and supernatant were store at -40°C.  Additional clean vaginal swabs were collected and 
processed as described above for use as a blank matrix for calibration samples. 
 
2.2 Immunochromatographic Assay Testing of Semen-free Samples 
Each vaginal swab sample was tested using RSID™-Semen, ABAcard® p30, and 
Seratec® PSA Semiquant following the manufacturer’s instructions.  One hundred 
microliters of sample extract supernatant was added to the sample well of each RSID™-
Semen immunoassay card. Next, 200 µL of each sample extract supernatant was added to 
the sample well of each ABAcard® p30 immunoassay card.  Finally, 120 µL of each 
sample extract supernatant was added to the sample well of a Seratec® PSA Semiquant 
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immunoassay card.  Sample volumes were based on manufacturer instructions and all 
immunoassay card results were recorded at a 10-minute cut-off time.  For all 3 
immunochromatographic tests, the presence of a pink line at the control region indicated 
the test was working properly.  The presence of a pink line solely at the control region 
indicated a negative reaction for all three tests.  For the ABAcard® p30 cassettes, the 
presence of a pink line at both the control and test region indicated the presence of prostate 
specific antigen and was recorded as a positive reaction.  For the RSID™-Semen cassettes, 
the presence of a pink line at both the control and test region indicated the presence of 
Semenogelin and was recorded as a positive reaction. For the Seratec® PSA Semiquant 
cassettes, the observation of a pink line at the control, test, and internal standard region 
indicated the presence of Prostate Specific Antigen and was recorded as a positive reaction.   
 
2.3 Microscopic Analysis of Semen-free Samples 
Microscopic analysis was completed using Sperm Hy-Liter™ Express following 
previously optimized in-house protocols.  All samples that yielded a positive result during 
immunochromatographic testing, as well as five samples yielding negative results were 
selected for microscopic analysis.  Sperm Hy-Liter™ Microscope Slides were labeled 
according to the samples being tested.  A 1X wash buffer was prepared by adding 2 mL of 
the provided 10X wash buffer to 18 mL of diH2O.  A Dithiothreitol (DTT) solution was 
prepared by adding 100 µL of DTT to 20 drops of the provided sample preparation solution.  
Fifteen microliters of each sample was added to its designated sample window and allowed 
to dry at room temperature.  Once the sample was dry, a drop of fixative solution was added 
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to each microscope slide and incubated at room temperature for 5 minutes. The fixative 
solution was then gently rinsed using the diluted 1X wash buffer.  Twenty-five microliters 
of the prepared DTT solution was added to each slide and incubated at room temperature 
for 10 minutes.  The DTT solution was then rinsed using the 1X wash buffer.  A drop of 
blocking solution was added to each slide and incubated at room temperature for a time 
period of 15 minutes.  The blocking solution was then gently rinsed using the 1X wash 
buffer. Next, a drop of the sperm head staining solution was added to each sample window 
and incubated at room temperature for 15 minutes. The sperm head staining solution was 
then rinsed with the 1X wash buffer. One drop of mounting media was then added to each 
sample window followed by an 18 mm x 18 mm micro cover glass (VWR™, Radnor PA). 
Any excess mounting media was gently removed with a tissue wiper (VWR™, Radnor PA) 
and the mounting media was left to harden for approximately 20 minutes.  Clear nail polish 
was applied outside the edges of the coverslip for stabilization.  Each slide was then 
analyzed using a fluorescence microscope with DAPI and Alexa 488 compatible filters. 
 
2.4 Sample Preparation of Semen-free Samples for LC-MS/MS Analysis 
Sample purification was performed on all samples prior to protein mass 
spectrometry analysis.  One hundred microliters of sample or calibrator supernatant (in 
Universal Buffer) was thoroughly vortexed with 900 µL of diH2O with 0.5% trifluoracetic 
acid (TFA) for a final volume of 1 mL.  
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2.4.1. Solid Phase Extraction #1 
Waters Oasis HLB reverse-phase extraction cartridges (Waters Corporation, 
Milford MA) were utilized for solid phase extraction on a Positive Pressure Vacuum 
Manifold (Biotage, Charlotte North Carolina). Cartridges were primed with 1 mL of 50% 
acetonitrile (ACN) with 0.5% TFA.  The vacuum was applied until all of the liquid passed 
through each cartridge. One milliliter of 0.5% TFA solution was used to equilibrate the 
extraction cartridges and the vacuum was applied until all the liquid passed through. One 
milliliter of the prepared sample or calibrator was added to each cartridge. Again, the 
vacuum was applied until all of the liquid passed through each cartridge. Next, the 
cartridges were washed using 1 mL of 0.5% TFA solution with a repeat pipettor and 
pressure was applied to run the liquid through the cartridge. Two-hundred microliters of 
elution solution comprised of 70% ACN 0.1% formic acid (FA) was added to each 
cartridge and purified material was eluted into glass test tubes. 
 
2.4.2 Plate Preparation and Dry Down  
Corning non-binding surface (NBS) treated 96-well plates (Corning®, Corning 
NY) were utilized for mass spectrometry analysis to limit molecular interactions and 
sample loss. Twenty microliters of internal positive control (IPC)(5 ng/µL), intact bovine 
myelin protein, was added to each sample or calibrator well using a repeat pipettor. Next, 
25 µL of 25 fmol/µL AQUA heavy isotope-labeled peptide standard for each target peptide 
was added to each well using a repeat pipettor.  Two-hundred microliters of eluent was 
added to the corresponding well.  Calibrators containing the target peptide sequences in 
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equal concentration were prepared through serial dilution in 30% ACN 0.1% FA.  Using a 
10 pmol/µL stock diluted with 30% ACN 0.1% FA, the calibration curve prepared covered 
peptide concentrations from 0.5 fmol/µL to 100 fmol/µL. Final calibrator concentrations 
are outlined in Table 1. The sample plate was covered with an optical adhesive film 
(Applied Biosystems®, Waltham MA), punched, and placed in a Savant™SPD111V 
SpeedVac Concentrator (ThermoFisher Scientific®, Waltham MA) and lyophilized to 
dryness. 
 
2.4.3. Robot Digest and Incubation   
 Denaturation solution containing 3.12 g of urea, 32.5 µL of 1M Tris (2-
carboyxyethyl) phosphine (TCEP, final concentration of 5mM), and 4 ml of 100 mM Tris 
hydrochloride (HCl) was prepared.  A 1M iodoacetamide (IAA) alkylation solution was 
prepared in diH2O, for a final concentration of 100 mM. Utilizing the AssayMAP Bravo 
liquid handling platform (Agilent, Santa Clara, CA) and the single plate digestion 
application in VWorks software (v. 2.0), 55 µL of denaturant solution was added to each 
well and allowed to incubate at 25ºC for 45 minutes. Six microliters of alkylation solution 
was added and samples were incubated at 25ºC for 30 minutes. Next, 200 µL of 100 mM 
Tris HCl was added to each sample and thoroughly mixed. Ten microliters of 0.25 µg/µL 
trypsin was added to each sample and allowed to incubate at 37ºC overnight (maximum of 
14 hours).   
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2.4.4 Solid Phase Extraction #2 and Plate Dry Down  
Ten microliters of 25% TFA in diH2O was added to each well. Next, 10 µL of 
secondary internal positive control (1 ng/µL), heavy isotope-labeled bovine myelin 
peptide, was added to each well. Utilizing the AssayMAP Bravo liquid handling platform 
and the peptide cleanup application in VWorks software, C18 microextraction cartridges 
(Agilent, Santa Clara, CA) were primed with 100 µL 50% ACN 0.5% TFA at 300 µL/min. 
Cartridges were then equilibrated with 50µL 0.5% TFA in diH2O at 10 µL/min. Next, 220 
µL of digested sample or calibrator was passed over the C18 sorbent at 5 µL/min.  Protein 
material was eluted from the cartridge with 25 µL of 70% ACN 0.1% FA at 5 µL/min into 
a 96-well PCR plate. When completed, the sample plate was placed on the SpeedVac 
Concentrator and lyophilized to dryness. 
 
2.5 Sample Collection, Solubilization, and Preparation of Post-Coital Samples 
 Post-coital samples were self-collected from 4 anonymous donors using sterile 
cotton swabs.  Samples were collected daily in duplicate starting the day after intercourse 
up to a period of eight days. Each swab was stored individually in a coin envelope, with a 
total of 61 swabs being collected. All samples were stored at -80°C until use.  For 
solubilization of the swabs, the cotton tip was removed with a sterile scalpel and placed in 
a 2.0 mL tube.  Each swab was solubilized in 1 mL of deionized water for 30 minutes with 
periodic vortexing every five minutes. Swab cuttings were placed in a spin basket and 
centrifuged for ten minutes at 12,000 rpm.  Nine-hundred fifty microliters of supernatant 
from each sample was transferred to a new 1.5 mL tube.  The pelleted cellular material and 
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swab cutting were retained in the original tube for genetic analysis. The pellet and 
supernatant were stored at -40°C.  Clean (i.e. semen-free) vaginal swabs were collected 
and processed as described above for use as blank matrix for calibration samples. The 
remainder of the sample preparation steps for the post-coital swabs were completed in 
accordance with the procedure of the semen free swabs, excluding the first solid phase 
extraction. 
 
2.6 Protein Mass Spectrometry  
Lyophilized samples or calibrators were reconstituted in 50 µL of 2% ACN in 
diH2O prior to analysis. The sample plate was placed in an Agilent 6495 Triple Quadrupole 
coupled to a 1290 series liquid chromatograph (Agilent Technologies®, Santa Clara CA). 
Ten microliters of sample or calibrator was injected into the liquid chromatograph. Target 
analytes [Table 2] were separated using an Agilent AdvancedBio Peptide Mapping Column 
(2.1 x 100 mm, 2.7 µm) over a 15-minute gradient [Table 3]. The multiple reaction 
monitoring (MRM) analytical method was developed, optimized, and validated under a 
previous study. The parameters for the LC-MS/MS are found in Table 4. Data was acquired 
and analyzed using the Agilent MassHunter software suite (v.08.00) and Skyline Targeted 
Proteomics software (v.4.1.0) (MacCoss Lab, University of Washington WA). 
 
 
 
 
21 
 
Table 1. Calibration Curve. This table shows the final concentration of the calibrators 
prior to the Robot Digest. 
 
Calibrator 
Final 
Concentration 
(fmol/µL) 
1 100 
2 50 
3 25 
4 10 
5 5 
6 1 
7 0.5 
 
 
 
Table 2. Target peptide analytes. 
 
Protein 
 
Peptide 
Precursor 
Mass 
(m/z) 
Product  
Mass 
(m/z) 
Retention  
Time  
(min) 
 
PSA 
 
LSEPAELTDKAVK 
 
636.8377 
943.5095 
646.3770 
472.2584 
 
6.1 
 
Semenogelin I 
 
QITIPSQEQEHSQK 
 
551.6128 
706.3442 
599.2784 
 
 
3.6 
 
Semenogelin II 
 
GSISIQTEEQIHGK 
 
509.5985 
691.8673 
635.3253 
461.5807 
 
4.3 
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Table 3. Chromatographic Separation.  
 
 
Time (min) 
Mobile Phase 
A - Water 
Mobile Phase 
B- 100%ACN 
Flow 
(mL/min) 
1 0.0 95.00% 5.00% 0.4 
2 12.5 65.00% 35.00% 0.4 
3 13.0 10.00% 90.00% 0.4 
4 14.90 95.00% 5.00% 0.4 
5 15.0 min 95.00% 5.00% 0.4 
 
   
 
 
 
 
  Table 4. Parameters of Mass Spectrometer. 
 
 
Source Parameters 
 
Value (+) 
Gas Temp (C) 150 
Gas Flow (l/min) 11 
Nebulizer (psi) 30 
Sheath Gas Heater 150 
Sheath Gas Flow 10 
Capillary (V) 3500 
V Charging 300 
Injection volume (µl) 10 
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2.7 DNA Analysis of Post-Coital Samples 
2.7.1 Differential Extraction of Post-Coital Samples 
 All post-coital samples selected for DNA analysis were extracted using PrepFiler 
Express™ Extraction Kit (ThermoFisher Scientific®, Waltham MA) on the AutoMate 
Express™ Forensic DNA Extraction System (ThermoFisher Scientific®, Waltham MA).  
A front-end differential extraction protocol was employed. A master mix was prepared 
using Extraction Buffer and Proteinase K solution in a conical tube and vortexed. Five-
hundred microliters of master mix was added to each 2.0 mL sample tube containing the 
pellet and swab cutting. Each 2.0 mL tube was then vortexed for 5 seconds and centrifuged 
for 2 seconds. The samples were placed on a thermal shaker preheated to 56ºC and set at 
900 rpm for a 40-minute incubation. Once the samples were removed from the thermal 
shaker, they were pulse spun for 5 seconds in the centrifuge. The swab cutting was then 
placed into a spin basket and each tube was centrifuged for 10 minutes at 13,000 rpm. The 
spin basket and cutting were discarded.  Four-hundred fifty microliters of the supernatant 
(epithelial fraction) was then removed from each sample tube while 50 µL was left with 
the pellet (sperm fraction).  The cell pellet was then re-suspended in 750 µL of ultrapure 
water.  Each sample was vortexed for 30 seconds and centrifuged at 13,000 rpm for 10 
minutes. Seven-hundred microliters of the supernatant was removed and discarded. The 
resuspension of the cell pellet was repeated for a total of 2 pellet washes. Next, a master 
mix of Lysis Buffer was prepared containing PrepFiler™ Lysis Buffer, Proteinase K 
Solution, and 1 M DTT solution. The Lysis Buffer master mix was vortexed and 500 µL 
was added to each sample tube. Each tube was vortexed for 5 seconds and centrifuged for 
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2 seconds. The samples were placed on a thermal shaker preheated to 70º and set at 750 
rpm for a 40-minute incubation period. Following the incubation, each sample was pulse 
spun for 5 seconds. Using sterile scissors, the hinge of each sample tube lid was cut and 
removed. Each sample was then placed on the AutoMate Express™ platform for DNA 
extraction.  
 
2.7.2 Chelex® Extraction of Reference Samples 
 All reference samples were extracted via a Chelex® Extraction.  A 5% Chelex® 
solution was made by adding 0.5 g of Chelex® 100 Resin (Bio-Rad, Hercules CA) to 10 
mL distilled water. Each reference swab was placed in a 2.0 mL tube.  One milliliter of 
deionized water was added to each tube and vortexed for 3 seconds. Next, the samples were 
placed on a thermomixer and incubated at 23ºC for 30 minutes at 850 RPM.  The samples 
were removed from the thermomixer and centrifuged for 5 seconds. Cuttings were then 
placed in a spin basket and centrifuged for 3 minutes at 14,000 rpm.  Following 
centrifugation, the spin baskets containing the swab were discarded.  Next, the supernatant 
was removed and discarded, leaving approximately 50 µL of liquid with the cellular 
material at the bottom of the tube.  One-hundred seventy-five microliters of 5% Chelex® 
was added to each sample.  The samples were vortexed thoroughly and then placed in an 
incubator set to 56ºC for 30 minutes.  Following incubation, the samples were vortexed for 
3 seconds and placed on a thermomixer set at 99ºC and 850 RPM for 8 minutes. The 
samples were removed from the thermomixer and vortexed for 3 seconds. Next, they were 
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placed in a microcentrifuge and spun for 3 minutes at 14,000 rpm. Each sample was then 
transferred to a labeled 1.5 mL tube and refrigerated until quantitation.  
 
2.7.3 Quantitation of Post-Coital & Reference Samples  
 Quantitation was completed using Quantifiler® Trio DNA Quantification Kit 
(Applied Biosystems®, Wilmington DE).  Standards were created using Quantifiler® THP 
DNA Standard and Quantifiler® THP Dilution Buffer in order to create a serial dilution. 
A master mix was created by combining 280.5 µL of Quantifiler® THP Reaction Mix and 
229.5 µL of Quantifiler® Primer Mix.  The standards and master mix were vortexed for 5 
seconds and pulse spun for 5 seconds. Nine microliters of the prepared master mix was 
added to each sample well of a MicroAmp® Optical 96-Well Reaction Plate (Applied 
Biosystems®, Wilmington DE).  Next, 1 µL of standard, negative control, sample, 
reference, or reagent control was added to each designated well. A MicroAmp™ Optical 
Adhesive Film (Applied Biosystems®, Wilmington DE) was placed on the well plate and 
the well plate was placed and run on an Applied Biosystems® 7500 Real Time PCR 
System.  
  
2.7.4. Amplification of Post-Coital and Reference Samples 
 Y-STR amplification was completed using Yfiler™Plus PCR Amplification Kit 
(Applied Biosystems®, Wilmington DE).  A master mix was created by combing 407 µL 
of Yfiler™ master mix and 203.5 µL of Yfiler™ Plus Primer Set to a 1.5 mL tube. Fifteen 
microliters of master mix were added to each control, sample, reference, and reagent 
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control tube. Depending on quantitation results and calculations, the necessary amount of 
TE-4 Buffer was added to any tube that required it.  Next, 2.50 µL of DNA Control 007 
was added to the Positive Control Tube. Each sample, reference, and reagent control was 
vortexed for 5 seconds and the calculated amount was added to the appropriate tube.  The 
samples were then placed and run on the Applied Biosystems® GeneAmp 9700 PCR 
Thermal Cycler (Applied Biosystems®, Wilmington DE). 
 Autosomal STR amplification was completed using a GlobalFiler™ PCR Reaction 
Amplification Kit (Applied Biosystems®, Wilmington DE). A master mix was created by 
combining 305.25 µL of GlobalFiler™ master mix and 101.75 µL of GlobalFiler™ Primer 
Mix in a 1.5 mL tube.  Ten microliters of master mix was added to each control, sample, 
reference, and reagent control tube.  Depending on quantitation results and calculations, 
the necessary amount of TE-4 Buffer was added to any tube that required it. Next, 2.50 µL 
of DNA Control 007 was added to the Positive Control Tube. Each sample, reference, and 
reagent control was vortexed for 5 seconds and the calculated amount was added to the 
appropriate tube.   The samples were then placed and run on the Applied Biosystems® 
GeneAmp 9700 PCR Thermal Cycler (Applied Biosystems®, Wilmington DE). 
 
2.7.5 Capillary Electrophoresis of Post-Coital & Reference Samples 
 A formamide solution was created by adding 10.5 µL of size standard into 4 
separate tubes of 250 µL of Hi-Di formamide.  The resulting formamide master mix was 
pooled into 1 vial. Next, 10 µL of the formamide master mix was added to each well.  Once 
this was completed 1 µL of either sample, control, or ladder was added to its designated 
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well. The plate was then analyzed using an Applied Biosystems® 3500 Genetic Analyzer 
(Applied Biosystems®, Wilmington DE) and GeneMapper® ID-X software 
(ThermoFisher®, Waltham MA). 
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3. RESULTS & DISCUSSION 
3.1 Immunochromatographic Assays Tested with Semen-free Samples 
 A total of 17 semen-free (clean) vaginal swabs exhibited false positive results on 
either one or a combination of RSID™-Semen, ABAcard® p30, and Seratec® PSA 
Semiquant immunochromatographic assays (Tables 5A/5B).  A total of 3 false positive 
results were observed using the Seratec® PSA Semiquant immunoassay cards [Figure 1]. 
Eleven false positive results were observed using the ABAcard® p30 cartridges [Figure 2]. 
A total of 3 false positive results were observed using the RSID™-Semen immunoassay 
cards [Figure 3].  
 
  
 
 
 
 
 
 
 
 
Figure 1. Image of PSA Semiquant false positive. False positive result of semen-free vaginal 
sample #4 (Batch #2) when testing for PSA using the Seratec® PSA Semiquant 
immunochromatographic assay.  A positive reaction is indicated by the presence of a pink line at 
the control, internal standard and test region.  
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Figure 2. Image of ABAcard® p30 false positive. False positive result of semen-free vaginal 
sample #14 (Batch #2) when testing for p30 using ABAcard® p30 immunochromatographic assay.  
A positive reaction is indicated by the presence of a line at both the control and test regions.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Image of RSID™-Semen false positive. False positive result of semen-free vaginal 
sample #39 (Batch #2) when testing for Semenogelin using the RSID™-Semen 
immunochromatographic assay. A positive reaction is indicated by the presence of a line at both 
the control and test regions. 
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3.3 Microscopic Analysis of Semen-free Samples 
 All samples resulting in a false positive result on the immunochromatographic 
assays, as well as a known semen sample, were treated with Sperm Hy-Liter™ Express 
and results were confirmed using a fluorescent microscope [Figures 4-5]. All false positive 
samples observed under the fluorescent microscope were negative for spermatozoa. The 
selected five samples that produced a true negative reaction when tested on the 
immunochromatographic assays were also confirmed negative when analyzed using Sperm 
Hy-Liter™.   
 Given those samples that tested positive on the immunochromatographic assays 
were reportedly sperm free, these results using Sperm Hy-Liter™ were expected.  
Moreover these data highlight the specificity limitation associated with 
immunochromatographic assays. Both lateral flow tests for PSA as well as Sg produced 
false positive results from semen-free vaginal fluid, showing there is cross-reactivity of 
these tests with vaginal fluid or non-specific binding events. 
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Figure 4. Microscopic image of positive control. Positive control viewed under a fluorescent 
microscope using an Alexa 488 compatible filter. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Microscopic image of sample #9. View of semen-free vaginal sample #9 (Batch #1) 
viewed under a fluorescent microscope using an Alexa 488 compatible filter. 
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3.3 Protein Mass Spectrometry of Semen-free Samples 
 All of the semen-free samples were analyzed on the LC-MS/MS quantitative 
proteomic assay, which targeted three seminal fluid markers (PSA, Sg I and Sg2). Protein 
mass spectrometry yielded negative results for all samples [Tables 5A and 5B]. A negative 
result was indicated by the lack of a peak detectable above noise or product ion ratios that 
differed from the IPC. Chromatography results for each peptide in the semen assay for 
sample #9 are depicted in Figures 6-11.  The myelin internal positive controls were 
incorporated to measure digest efficiency. The myelin light peptides were consistent 
throughout all samples, showing that trypsin was functional as a protease and successful 
digestion was achieved.  Calibration curves met the criteria of acceptance for both 
SWGDAM AND SWGTOX guidelines with correlation coefficients above 0.9836, 37  
[Figure 12].  
Sensitivity of the quantitative proteomic mass spectrometry assay had already been 
shown to be orders of magnitude greater in sensitive as compared to the 
immunochromatographic assays used in an internal study (data not shown). Negative 
results for all clean vaginal samples on the mass spectrometer when targeting seminal fluid 
specific peptides, therefore, highlight the rate of true false positive results using all 3 
immunochromatographic assays.  These data demonstrate that protein mass spectrometry 
is a more specific technique for semen identification.  
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Table 5A. Immunochromatographic assay, protein mass spectrometry, and 
microscopic analysis results. Results from semen-free vaginal samples 1-25 (Batch #1). 
 
 
 
 
 
 
34 
Table 5B. Immunochromatographic assay, protein mass spectrometry, and 
microscopic analysis results. Results from semen-free vaginal samples 26-50 (Batch #2). 
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Figure 6. Chromatography result of sample #9. Negative chromatography result 
analyzing LSEP (PSA) peptide of semen-free vaginal sample #9 (Batch #1).  Product ion 
ratios failed acceptance criteria and low intensity value indicate a negative result for the 
presence of the LSEP peptide. 
 
 
 
Figure 7. Chromatography result of sample #9 IPC. Chromatography of LSEP peptide 
Internal Positive Control.  
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Figure 8. Chromatography result of sample #9. Negative chromatography result 
analyzing QITI (SgI) peptide of semen-free vaginal sample #9 (Batch #1). Lack of a peak 
at the 3.6 minute retention time indicates a negative result for the presence of the QITI 
peptide. 
 
 
 
 
Figure 9. Chromatography result of sample #9 IPC. Chromatography of QITI peptide 
Internal Positive Control. 
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Figure 10. Chromatography result of sample #9. Negative chromatography result 
analyzing GSIS (SgII) peptide of semen-free vaginal sample #9 (Batch #1). Lack of a peak 
at the 4.3 retention time indicates a negative result for the presence of the GSIS peptide. 
 
 
 
 
 
 
Figure 11. Chromatography result of sample #9 IPC. Chromatography of GSIS 
peptide Internal Positive Control. 
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Figure 12. Calibration curve for QITI peptide. QITI calibration curve meets 
acceptance criteria with a r2 value of 0.99. 
 
3.4 Protein Mass Spectrometry of Post-Coital Samples 
For protein analysis, a positive result was recorded if at least 1 of the seminal fluid 
peptides had a concentration value above the limit of quantitation (0.50 fmol/ µL). The 
limit of detection for each seminal fluid peptide was 0.25 fmol/ µL.  A total of 48 post-
coital samples analyzed on the LC-MS/MS reached the level of quantitation for PSA, SgI, 
or SgII peptide targets. Sample #1 had a peptide concentration value about the limit of 
quantitation for each peptide with reported concentrations of 1.69, 1.06, and 0.83 fmol/ µL 
for PSA, SgI and SgII peptides, respectively. A positive result for each peptide for Sample 
#1 can be visualized in Figures 13-18.  Despite having lower peptide concentration levels 
around the limit of quantitation (but above the limit of detection), sample #33 exhibited a 
positive chromatographic result that can still be easily visualized with reported peptide 
concentrations of 0.49, 0.58, and 0.55 fmol/ µL for PSA, SgI, and SgII, respectively 
[Figures 19-21]. 
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The myelin internal positive control was incorporated to measure digest efficiency. 
Myelin light peptides were consistent throughout all samples, indicating trypsin was 
functional as a protease.  Calibration curves met the criteria of acceptance of an r2 value 
above 0.98 for both SWGDAM AND SWGTOX guidelines36, 37 [Figure 22]. 
 
 
 
 
 
Figure 13. Chromatography result of sample #1. Positive chromatography result 
analyzing the LSEP (PSA) peptide of post-coital Sample #1 (Batch #1). A positive result 
for PSA is indicated by the presence of a peak at the same retention time and containing 
the same product ion ratios as the LSEP IPC [Figure 14]. 
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Figure 14. Chromatography result of sample #1 IPC. Chromatography result of LSEP 
peptide Internal Positive Control. 
 
 
 
 
 
 
 
 
 
Figure 15. Chromatography result of sample #1. Positive chromatography result 
analyzing QITI (SgI) peptide of post-coital sample #1 (Batch #1).  A positive result for the 
presence of SgI is indicated by the presence of a peak at the same retention time and the 
same peak height ratios as the QITI IPC [Figure 16].  
 
 
41 
 
 
 
 
Figure 16. Chromatography result of sample #1 IPC. Chromatography result of QITI 
peptide Internal Positive Control.  
 
 
 
 
 
 
Figure 17. Chromatography result of sample #1. Positive chromatography result 
analyzing the GSIS (SgII) peptide for post-coital sample #1 (Batch #1). A positive result 
for the presence of SgII is indicated by the presence of a peak with the same peak height 
ratios as the GSIS IPC [Figure 18]. 
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Figure 18. Chromatography result for sample #1 IPC.  Chromatography result for the 
GSIS peptide Internal Positive Control. 
 
 
 
 
 
 
Figure 19. Chromatography result of sample #33. Positive chromatography result 
analyzing the LSEP (PSA) peptide for post-coital sample #33 (Batch #1).  Despite a low 
quantitation of the peptide, a positive result for PSA is still indicated by a peak at the correct 
retention time and peak height ratios.  
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Figure 20. Chromatography result of sample #33. Positive chromatography result 
analyzing the QITI peptide of post-coital sample #33 (Batch #1). Despite a low quantitation 
of the peptide, a positive result is still indicated for the presence of SgI by a peak at the 
correct retention time and peak height ratios. 
 
 
 
 
 
Figure 21. Chromatography result of sample #33. Positive chromatography result 
analyzing the GSIS peptide of post-coital sample #33 (Batch #1). Despite a low 
quantitation of the peptide, a positive result is still indicated for the presence of SgII by a 
peak at the correct retention time and peak height ratios. 
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Figure 22. Calibration Curve for LSEP Peptide.  LSEP calibration curve meets 
acceptance criteria with a r2 value of 0.99. 
 
 
 
3.5 DNA Analysis of Post-Coital Samples 
 Twenty-six post-coital samples were selected for DNA Analysis. All samples 
analyzed consisted of the first swab that was collected by volunteers in a given day.  Four 
post-coital samples resulted in full autosomal STR profiles, while 5 resulted in partial STR 
profiles [Table 6]. Figures 23A-23C show a full autosomal profile generated from sample 
#48. A complete autosomal profile was generated up through 5 days post-coitus. The 
reference profiles can be found in Appendix A. 
 Six samples resulted in a full Y-STR profile while 4 samples resulted in a partial 
Y-STR profile. Both full and partial Y-STR profiles were able to be observed up to 5 days 
post-coitus. Figures 24A-24B depict a full Y-STR profile from sample #48. The Y-STR 
reference profiles can be found in Appendix B.   
 All samples that were able to generate an autosomal or Y-STR profile had tested 
positive for at least 1 of the 3 seminal fluid markers using protein mass spectrometry. 
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However, with this limited sample set, there did not appear to be a correlation between 
peptide quantitation and subsequent ability to generate a full or partial genetic profile. The 
data in Table 6 shows a DNA profile was able to be obtained from a variety of peptide 
concentrations. In the future, a study with a larger number of samples could help establish 
whether or not a correlation truly exists between seminal fluid peptide concentration and 
STR results.   
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Table 6. Mass Spectrometry and DNA Analysis Results. For peptide concentration, a 
red cell indicates a concentration below the limit of detection, a yellow cell indicates a 
concentration between the limit of detection and quantitation, and a green cell indicates a 
concentration at or above the level of quantitation. For the DNA profiles, a red cell 
indicates no profile was detected (0-1 alleles), while a green cell indicates that a profile 
was present (2+ alleles).  
 
 
Sample 
# 
 
Day 
PC 
 
LSEP 
Conc. 
(fmol/ 
µL) 
 
QITI 
Conc. 
(fmol/ 
µL) 
 
GSIS 
Conc. 
(fmol/ 
µL) 
STR 
Alleles 
Present 
Y-STR 
Alleles 
Present 
Percent 
of STR 
Alleles 
Percent 
of Y-
STR 
Alleles 
3 2 0.49 0.55 0.54 0 0 0 0 
4 3 0.49 0.54 0.54 0 0 0 0 
6 4 0.49 0.54 0.54 0 0 0 0 
8 5 0.70 0.61 0.53 0 1 0 3.84 
10 6 0.48 0.55 0.52 0 0 0 0 
18 3 0.49 0.55 0.52 0 0 0 0 
20 4 0.49 0.56 0.52 0 0 0 0 
22 5 0.48 0.54 0.52 0 0 0 0 
24 6 0.48 0.53 0.52 0 0 0 0 
28 4 0.48 0.68 0.63 0 0 0 0 
30 5 0.49 0.57 0.56 0 0 0 0 
32 6 0.48 0.54 0.52 0 0 0 0 
34 7 0.87 0.82 1.59 0 0 0 0 
36 3 0.21 0.19 1.61 21 14 51.22 53.85 
38 4 0.19 0.26 0.30 0 0 0 0 
40 5 0.19 0.24 1.77 0 0 0 0 
42 6 0.19 0.21 0.30 0 0 0 0 
44 1 15.10 585.96 71.51 37 0 100 0 
46 2 0.77 104.16 13.56 37 28 100 100 
48 3 0.23 15.94 3.96 37 28 100 100 
50 4 0.19 1.73 0.83 37 28 100 100 
52 5 0.19 0.57 0.43 35 28 94.59 100 
54 1 4.42 0.26 0.47 39 26 95.12 100 
56 2 0.27 0.19 0.31 23 24 56.10 92.31 
58 3 0.23 0.22 0.31 29 26 70.73 100 
60 4 0.20 0.21 0.29 0 16 0 61.54 
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Figure 23A. Autosomal STR profile of sample #48. Full DNA profile of post-coital sample #48 
(Reference 4 in Appendix A). 
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Figure 23B. Autosomal STR profile of sample #48. Full DNA profile of post-coital sample #48 
(Reference 4 in Appendix A). 
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Figure 23C. Autosomal STR profile of sample #48. Full DNA profile of post-coital sample #48 
(Reference 4 in Appendix A). 
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Figure 24A. Y-STR profile of sample #48. Full DNA profile of post-coital sample #48 
(Reference 4 in Appendix B) 
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Figure 24B. Y-STR profile of sample #48. Full DNA profile of post-coital sample #48 
(Reference 4 in Appendix B). 
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4. CONCLUSIONS 
4.1 Semen-free Samples 
 A total of 17 out of 150 (11.3%) immunochromatographic assays yielded a false 
positive result when testing for either prostate specific antigen or semenogelin.  Three false 
positives were noted for both RSID™ Semen and the Seratec® PSA Semiquant test (false 
positive rate of 2% each), while 11 false positive results were observed with the ABAcard® 
p30 assay (false positive rate of 7.3%).  These data suggest that these assays should be used 
for presumptive indication of seminal fluid only. Protein mass spectrometry yielded no 
false positive results for seminal fluid markers, providing support that the technique can be 
used as an alternative serological approach with improved specificity for body fluid 
identification.  
 
4.2 Post-Coital Samples 
 A total of 48 out of 61 post-coital samples yielded a positive result when testing for 
Prostate Specific Antigen or Semenogelin using protein mass spectrometry. This provides 
further support that protein mass spectrometry could be a viable confirmatory technique 
for body fluid identification. Nine samples that tested positive for the three seminal fluid 
proteins were able to develop at least a partial autosomal STR profile, while 10 samples 
were able to develop at least a partial Y-STR profile. Although a correlation between 
peptide quantitation and ability to generate a genetic profile was not evident given this 
limited sample set, future experiments with an increased sample size could help further 
assess whether some correlation can be established.   
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APPENDIX A:  Autosomal STR Reference Profiles for Post-Coital Samples 
Male Reference 1: 
 
54 
 
 
 
 
 
 
 
 
55 
Male Reference 2: 
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Male Reference 3: 
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Male Reference 4: 
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62 
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APPENDIX B: Y-STR Reference Profiles for Post-Coital Samples 
Male Reference 1: 
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Male Reference 2: 
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Male Reference 3: 
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Male Reference 4:  
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